SCHEMBL31079121

SCHEMBL31079121

COc1cc(Br)ccc1NC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 1/20 0.57
MAPT P10636 4/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
POLB P06746 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
GAA P10253 2/20 0.49
RECQL P46063 1/20 0.49
ALDH1A1 P00352 5/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
RXFP1 Q9HBX9 2/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2076016 1.00 LPAR1 (0.57) LPAR1MAPTNPC1RAB9APOLB
SCHEMBL14721362 0.86 ALDH1A1 (0.52) MAPTNPC1RAB9APOLBMEN1
SCHEMBL29475122 0.86 LPAR1 (0.57) LPAR1MAPTNPC1RAB9APOLB
SCHEMBL3504431 0.86 LPAR1 (0.57) LPAR1MAPTNPC1RAB9APOLB
SCHEMBL21198563 0.83 LPAR1 (0.61) LPAR1MAPTNPC1RAB9APOLB
SCHEMBL30823737 0.83 LPAR1 (0.61) LPAR1MAPTNPC1RAB9APOLB
SCHEMBL19643985 0.82 LPAR1 (0.60) LPAR1MAPTNPC1RAB9APOLB
SCHEMBL21217705 0.82 HTT (0.72) LPAR1MAPTRAB9AMEN1KMT2A
SCHEMBL31630583 0.82 LPAR1 (0.53) LPAR1MAPTNPC1RAB9APOLB
SCHEMBL1238843 0.81 CYP1A2 (0.54) LPAR1MAPTNPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651872-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS Septerna, Inc. (US) 2025-11-26 EP disclosed
WO-2024155601-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS SEPTERNA, INC. (US) 2024-07-25 WO disclosed